Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.626, 2011-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Response-guided protocol rules in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :
Perspectives in therapy for hepatitis C
By Vento Sandro Cainelli Francesca Temesgen Zelalem
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. :
IM hepatitis B immune globulin cost saving after liver transplantation
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :
Which therapy option most cost effective in hepatitis C?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. :
New horizons in hepatitis C therapy
Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. :